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OBJECTIVE
We examine differences in prevalence of diabetes and rates of awareness and
control among adults from diverse Hispanic/Latino backgrounds in the Hispanic
Community Health Study/Study of Latinos (HCHS/SOL).
RESEARCH DESIGN AND METHODS
The HCHS/SOL, a prospective, multicenter, population-based study, enrolled from
four U.S. metropolitan areas from 2008 to 2011 16,415 18–74-year-old people of
Hispanic/Latino descent. Diabetes was defined by either fasting plasma glucose,
impaired glucose tolerance 2 h after a glucose load, glycosylated hemoglobin
(A1C), or documented use of hypoglycemic agents (scanned medications).
RESULTS
Diabetes prevalence varied from 10.2% in South Americans and 13.4% in Cubans
to 17.7% in Central Americans, 18.0% in Dominicans and Puerto Ricans, and 18.3%
in Mexicans (P < 0.0001). Prevalence related positively to age (P < 0.0001), BMI
(P < 0.0001), and years living in the U.S. (P = 0.0010) but was negatively related to
education (P = 0.0005) and household income (P = 0.0043). Rate of diabetes
awareness was 58.7%, adequate glycemic control (A1C <7%, 53 mmol/mol) was
48.0%, and having health insurance among those with diabetes was 52.4%.
CONCLUSIONS
Present findings indicate a high prevalence of diabetes but considerable diversity
as a function of Hispanic background. The low rates of diabetes awareness, diabetes
control, and health insurance in conjunction with the negative associations between
diabetes prevalence and both household income and education among Hispanics/
Latinos in the U.S. have important implications for public health policies.
The Centers for Disease Control and Prevention (CDC) has reported that the prev-
alence of diabetes (self-reported and undiagnosed) in the U.S. is 10.2% for non-
Hispanic whites aged 20 years or older and 18.7% for non-Hispanic blacks of the
same age (1). According to the CDC, sufficient data are not yet available to estimate
the total prevalence of diabetes for other U.S. racial/ethnic minority populations.
This includes the 50.5 million Hispanics/Latinos who comprise 16% of the U.S.
population (2). In part because of the gap in information about Hispanic/Latino
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health, the Hispanic Community Health
Study/Study of Latinos (HCHS/SOL) was
launched by the National Heart, Lung,
and Blood Institute (NHLBI) and six
other institutes, centers, and offices of
the National Institutes of Health to ex-
amine the prevalence and development
of chronic diseases, including diabetes,
among people of diverse Hispanic/
Latino backgrounds living in the U.S.
Although the CDC indicated that
there was insufficient information to
provide a prevalence estimate for diabe-
tes in Hispanic/Latinos, they did cite
data concerning self-reported diabetes
in this population obtained from 2007–
2009 by the National Health Interview
Survey (NHIS) (1). This study indicated
that after age adjustment, 7.1% of
non-Hispanic whites, 8.4% of Asian
Americans, 11.8% of Hispanics/Latinos,
and 12.6% of non-Hispanic blacks
self-reported having diabetes. There
was considerable diversity among
Hispanics/Latinos, as rates for Cubans
and Central and South Americans were
both 7.6%, whereas the rate was 13.3%
for Mexican Americans and 13.8% for
Puerto Ricans. However, national prev-
alence estimates for Cubans, Central
and South Americans, and Puerto Ricans
are less precise than they are for Mexi-
can Americans, as indicated by the rela-
tively large SEs for the estimates (3). In
the HCHS/SOL, it was possible to obtain
more precise prevalence estimates for
the various Hispanic/Latino groups us-
ing objective criteria for assessing diabe-
tes. The aim of this article is to describe
the prevalence of diabetes in U.S. His-
panics/Latinos from diverse Hispanic
backgrounds. Further, we describe the
prevalence of diabetes in the HCHS/
SOL by age, sex, BMI, length of time liv-
ing in the U.S. and socioeconomic sta-
tus. Among these participants with
diabetes, we present data on diabetes
awareness, glycemic control, and health
insurance.
RESEARCH DESIGN AND METHODS
The HCHS/SOL is a study of 16,415
women and men aged 18–74 years at
screening from randomly selected
households recruited during 2008–
2011 from Bronx, NY; Chicago, IL;
Miami-Dade County, FL; and San Diego,
CA. The HCHS/SOL cohort was selected
through a stratified multistage area
probability sample of four communities
(4). The selected communities are di-
verse regions of the U.S., from 4 of the
11 urban metropolitan areas with the
largest number of Hispanics/Latinos
(5). Even though the target population
for the HCHS/SOL is the four selected
communities, not the entire U.S. His-
panic/Latino population, each commu-
nity has high concentrations of specific
Hispanic/Latino backgrounds, allowing
the study to estimate prevalence of dis-
eases and risk factors for each back-
ground. In order to obtain diabetes
prevalence estimates taking into ac-
count age, sex, and Hispanic background
distribution, nonresponse adjusted,
trimmed, and calibrated weights were
used to approximate the census 2010
target population (2). The age, sex, and
Hispanic background distributions
based on the sampling weighted esti-
mates are very similar to the census
2010 target population, with the differ-
ences less than 1.6% and in most cases
less than 0.45%.
Population-based sampling was used
to identify and recruit HCHS/SOL partic-
ipants (4). Rosters of eligible participants
were generated for each household
sampled, and eligibility screening took
place through telephone calls or in-
person visits. Eligible participants were
community-dwelling adults who self-
identified as Hispanic or Latino, were
able to travel to a local field center for
examination, were not on active mili-
tary duty or pregnant, and did not plan
to move from the study area within
3 years. Census tracts were selected
to provide an adequate number of
Hispanics/Latinos that included di-
versity in socioeconomic status and
study-wide diversity in Hispanic/Latino
background. The rostered, eligible indi-
viduals were further sampledwithin age
strata so that there were 9,714 partici-
pants aged 45–74 years (59%) and 6,701
participants aged 18–44 years (41%). Of
screened individuals who were eligible,
42% were enrolled. All participants pro-
vided informed consent, and the study
had institutional review board approval
from each institution participating in
the study.
Study Procedures
Each participant had a clinical examina-
tion that included completion of clinical
assessments and questionnaires and
measurement of height and weight (6).
The study used standardized instru-
ments to determine information about
health behaviors, medical history, and
demographics. Study procedures in-
cluded a 2-h oral glucose tolerance test
(OGTT) except for those who had fasting
plasma glucose (FPG) .150 mg/dL and
those reporting being previously diag-
nosed with diabetes. Participants were
required to fast for at least 8 h prior to
the visit, consuming only water and nec-
essarymedications. Venous blood speci-
mens were collected, processed, and
frozen on site toward the beginning of
the visit and also 2 h after a 75 g glucose
load. Plasma glucose was assessed
using a hexokinase enzymatic method
(Roche Diagnostics Corporation, Indian-
apolis, IN). Glycosylated hemoglobin
(A1C) was measured in EDTA whole
blood using a Tosoh G7 automated
high-performance liquid chromatogra-
phy analyzer (Tosoh Bioscience Inc.,
San Francisco, CA). Throughout the
3-year exam period, collection of blinded
repeat blood samples and repeated ran-
dom measurements of clinical proce-
dures were used as quality control
procedures.
Self-report obtained by interview
with certified assessors was used to de-
fine personal and family history of med-
ical diagnoses such as diabetes; being
aware of diabetes; and demographic
variables, including age, sex, Hispanic/
Latino background, income, education,
and length of residence in the U.S. (but
not territories). Height and weight were
measured to the nearest 1.0 cm and 0.1
kg, respectively, with participants wear-
ing light clothing. BMI was calculated as
kg/m2. Inventory methods were used to
list all currently used medications. Dia-
betes was defined as either FPG $126
mg/dL (7 mmol/L), a 2-h postload glu-
cose level (2-h OGTT) $200 mg/dL
(11.2 mmol/L), A1C level $6.5%
(48 mmol/mol), or documented use of
hypoglycemic agents (scanned medica-
tions). The American Diabetes Asso-
ciation goal for A1C level of ,7.0%
(53 mmol/mol) was used to define gly-
cemic control.
Statistical Analyses
Statistical analyses were conducted
upon 16,385 participants with nonmiss-
ing diabetes data. Descriptive character-
istics, age standardized to the 2010 U.S.
population, were computed by sex and
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for all participants by Hispanic/Latino
background. All reported prevalence
values were weighted to adjust for sam-
pling probability and nonresponse, trim-
ming to handle extreme values of the
weights, and calibration to the known
population distribution (4). Statistical
analyses examined the prevalence of
diabetes by sex, age, Hispanic back-
ground, field center, BMI, education,
household income, and years living in
the U.S. and determined rates of diabe-
tes awareness, glycemic control, and
health insurance status as well. Logistic
regression models were analyzed and
included the variables of interest ad-
justed for selected covariates. Statistical
tests were two-sided at a significance
level of 0.05, but adjustments were not
made for multiple comparisons. All an-
alyses were performed using SAS version
9.2 (SAS Institute) and SUDAAN release
10.0.0 (RTI).
RESULTS
The prevalence of diabetes by Hispanic/
Latino background, sex, age, and BMI
assessed at the baseline exam by objec-
tive measures (FPG, 2-h OGTT, A1C,
or scanned medications) are shown in
Table 1. Because some epidemiological
studies, including the National Health
and Nutrition’s Examination Survey
(NHANES), used self-report to estimate
diabetes prevalence, we provide diabe-
tes prevalence data in part derived from
self-report in Supplementary Table 1.
Total prevalence of diabetes in persons
aged 18–74 years (Table 1) was 16.9%.
The unweighted prevalence of diabetes
in the HCHS/SOL was 19.6%, including
3,211 of 16,385 participants having di-
abetes. Weighted prevalence for diabe-
teswas similar formen andwomen after
controlling for age, BMI, Hispanic back-
ground, field center, and years lived in
the U.S. (men = 15.3%; women = 14.2%;
P = 0.0941).
In Table 1, the lowest prevalence es-
timates based on objective measure-
ments of HCHS/SOL participants were
for South Americans (10.2%) and
Cubans (13.4%). Central Americans
(17.7%), Dominicans (18.0%), Puerto Ri-
cans (18.0%), and Mexicans (18.3%) had
notably higher rates of diabetes. Differ-
ences in diabetes prevalence as a func-
tion of Hispanic/Latino background
remained significant after adjusting for
age, sex, BMI, field center, and years
lived in the U.S. (P , 0.0001). Diabetes
prevalence increased with age from
2.6% for those aged 18–29 years to
48.4% in those 70–74 years. Differences
in diabetes as a function of age were
significant after adjusting for sex, BMI,
Hispanic/Latino background, field cen-
ter, and years lived in the U.S. (P ,
0.0001). Diabetes prevalence similarly
increased as a function of BMI from
9.8% in those with BMI ,25 kg/m2 to
22.3% in those with BMI $30 kg/m2.
The difference in diabetes prevalence
as a function of BMI remained significant
after adjusting for age, sex, Hispanic/
Latino background, field center, and
years lived in the U.S. (P , 0.0001).
At the baseline exam, 11.9% of
women and men reported having pre-
viously been diagnosed with diabetes,
whereas 6.2% of participants were
newly classified as having diabetes on
the basis of FPG, 2-h OGTT, A1C, or
scanned hypoglycemic medications.
The prevalence of diabetes was signi-
ficantly related to length of residence in
the U.S. (Fig. 1) after adjustment for age
and sex (P = 0.0010); 11.8% of those
with diabetes were born in the U.S. Af-
ter adjustment for age, sex, BMI, His-
panic background, and field center,
those living in the U.S. for 5 years or
less did not differ significantly from
Table 1—Prevalence of diabetes by sex, Hispanic/Latino background, age, and BMI
Men and women Women Men
Sample size
Prevalence
(95% CI) Sample size
Prevalence
(95% CI) Sample size
Prevalence
(95% CI)
Overall 16,385 16.9 (16.11–17.69) 9,820 17.1 (16.16–18.19) 6,565 16.5 (15.41–17.71)
Hispanic background
Dominican 1,470 18.1 (16.21–20.13) 961 18.2 (15.60–21.08) 509 18.0 (14.83–21.71)
Central American 1,730 17.7 (15.36–20.22) 1,047 18.5 (15.59–21.82) 683 16.9 (13.75–20.57)
Cuban 2,347 13.4 (12.03–14.91) 1,249 13.5 (11.64–15.55) 1,098 13.2 (11.45–15.14)
Mexican 6,466 18.3 (16.84–19.86) 4,018 17.9 (16.18–19.74) 2,448 18.7 (16.32–21.33)
Puerto Rican 2,719 18.1 (16.30–19.98) 1,586 19.5 (16.98–22.23) 1,133 16.6 (14.31–19.27)
South American 1,070 10.2 (8.36–12.29) 634 9.8 (7.73–12.36) 436 10.6 (7.85–14.09)
Mixed/other 502 21.2 (15.74–27.88) 276 22.1 (14.92–31.49) 226 19.6 (13.64–27.29)
Missing 81 57.4 (46.58–67.57) 49 64.3 (51.10–75.62) 32 43.1 (30.36–56.92)
Age group, years
18–29 2,675 2.6 (1.93–3.36) 1,427 2.9 (1.98–4.11) 1,248 2.2 (1.49–3.38)
30–39 2,389 6.7 (5.49–8.15) 1,384 6.4 (4.94–8.31) 1,005 7.0 (5.23–9.28)
40–49 4,204 14.1 (12.64–15.69) 2,573 14.5 (12.68–16.59) 1,631 13.6 (11.50–16.07)
50–59 4,330 25.0 (23.06–27.09) 2,727 26.2 (23.47–29.08) 1,603 23.6 (21.03–26.32)
60–69 2,287 38.7 (35.64–41.79) 1,396 37.3 (33.44–41.28) 891 40.3 (36.00–44.73)
70–74 500 48.6 (41.57–55.64) 313 51.3 (42.17–60.36) 187 44.3 (34.67–54.34)
BMI, kg/m2
,25 3,317 9.8 (8.56–11.24) 1,942 9.5 (7.90–11.42) 1,375 10.2 (8.33–12.52)
$25 , 30 6,108 14.2 (13.10–15.35) 3,375 13.5 (11.98–15.12) 2,733 15.0 (13.39–16.67)
$30 6,897 22.4 (21.08–23.69) 4,470 23.1 (21.39–24.89) 2,427 21.4 (19.49–23.41)
Missing 63 31.3 (20.36–44.88) 33 31.9 (18.27–49.49) 30 33.6 (21.79–47.83)
Diabetes is based on FPG, 2-h OGTT, A1C, or scanned medications. Values except sample size are weighted for study design and nonresponse, and
age is standardized to Census 2010 U.S. population.
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those born in the U.S. (P = 0.8551),
whereas those living 10 or more years
in the U.S. did differ significantly from
those born in the U.S. (P = 0.0162) or
who lived in the U.S. for 10 years or
less (P = 0.0232).
Women with more than a high school
education had a lower prevalence of di-
abetes than those having a high school
education or less; men who had at
least a high school education had a lower
prevalence of diabetes than men with
less than a high school education (Fig.
2A). The negative association of diabetes
prevalence with education remained sta-
tistically significant after adjusting for
age, sex, BMI, Hispanic/Latino back-
ground, field center, and length of resi-
dence in the U.S. (P = 0.0005). Similarly,
women from higher-income households
had a lower prevalence of diabetes than
women from lower-income households,
but the gradient relating prevalence of
diabetes to household income was less
steep formen (Fig. 2B). After adjustments
for age, sex, BMI, Hispanic/Latino back-
ground, field center, and length of time
living in the U.S., the negative association
of diabetes prevalence with household
income was statistically significant (P =
0.0043); the interaction for household in-
come and sex was not (P = 0.4411).
Among HCHS/SOL participants with
objectively defined diabetes, 58.7% in-
dicated awareness of their condition,
48% displayed adequate diabetes con-
trol (A1C ,7%; 53 mmol/mol), and
52.4% reported having health insur-
ance. The rate of diabetes awareness,
glycemic control, and having health in-
surance among participants in three age
groups is shown in Fig. 3. After control-
ling for sex, Hispanic/Latino back-
ground, BMI, field center, education,
and years living in the U.S., the percent-
age of participants with health insur-
ance (P = 0.0001), diabetes awareness
(P = 0.0011), and glycemic control (P =
0.0299) increased significantly with age.
After controlling for the same vari-
ables, those 65 years and older revealed
greater rates of diabetes awareness (P =
0.0001), control (P = 0.0106), and insur-
ance coverage (P = 0.0001) than those
who were younger. Following adjust-
ment for the same variables, individuals
who were aware of their diabetes
showed greater diabetes control than
those who were unaware (P = 0.0001),
and those who had health insurance
were more likely to be aware than those
who did not (P = 0.0001). Individuals
with health insurance were less likely
among all participants (5 vs. 6.5%) to
present at the clinic exam with unrecog-
nized diabetes (P = 0.0030).
CONCLUSIONS
The total prevalence of diabetes for per-
sons aged 18–74 years was 16.9% andwas
similar in men and women. Significant dif-
ferences in diabetes prevalence were re-
lated to Hispanic/Latino background.
Based upon analyses of HCHS/SOL data,
Figure 1—Prevalence (and SE) of diabetes related to length of residence in the U.S. or being born in the U.S. Data are weighted and age standardized
using the 2010 U.S. population census.
Figure 2—Prevalence (and SE) of diabetes
related to (A) education and (B) household
income. Data are weighted and age stan-
dardized using 2010 U.S. population census.
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prevalence ranged from 10.2% in South
Americans to 18.3% inMexicans. Although
using a somewhat different metric in per-
sons 20 years or older from 2007–2009
and sex and age standardized to the
2000 U.S. population (our data are from
2008–2011 and age standardized to the
2010 U.S. population), the CDC has
reported a prevalence estimate of 10.2%
in non-Hispanic whites and 18.7% for non-
Hispanic blacks (1). Thus the range of
diabetes prevalence among Hispanics/La-
tinos appears to approximate the preva-
lence range between non-Hispanic
whites and non-Hispanic blacks. More-
over, the diversity in diabetes prevalence
across Hispanic/Latino heritage groups is
consistent with there being other varia-
tions in cardiovascular disease risk factors
observed among Hispanic/Latino-
background groups in the HCHS/SOL (8).
The prevalence of diabetes self-
reported at the HCHS/SOL baseline visit
was 11.9%, and the prevalence recog-
nized at baseline was 6.2%. Thus 34.3%
of HCHS/SOL participants with diabetes
were first detected at the baseline visit.
This percentage of HCHS/SOLparticipants
with diabetes first detected consequent
to the clinic exam is comparable to the
37.5% of non-Hispanic whites first iden-
tified consequent to the NHANES clinic
exam in 2005–2006, but age and sex
standardized to the 2000 U.S. census (9),
with the NHANES exam data based solely
on FPG.
By merging the results of two earlier
surveys, it was possible to compare es-
timates in the total prevalence of self-
reported and undiagnosed diabetes
among 20–74-year-old blacks, whites,
Cuban Americans, Mexican Americans,
and Puerto Ricans living in the U.S.
(10). This was achieved by combining
data analysis of the 1976–1980 NHANES
study of blacks and whites and the His-
panic Health and Nutrition Examination
Survey of 1982–1984 that examined
Mexican Americans in the Southwest,
Cuban Americans in Miami, and Puerto
Ricans in New York City and surround-
ings. The combined study reported an
age-standardized prevalence of diabe-
tes of 6.2% in whites, 9.3% in Cubans,
10.2% in blacks, 13.0% inMexican Amer-
icans, and 13.4% in Puerto Ricans. Al-
though the prevalence of diabetes
observed from 1976–1984 was far lower
than that observed after 2007, the di-
versity of diabetes prevalence across ra-
cial/ethnic groups has continued and
occurs in approximately the same rank
order.
Prevalence of diabetes significantly
increased in relation to length of resi-
dence in the U.S., both in the HCHS/
SOL and in the 1997–2005 study by the
NHIS (11). The HCHS/SOL, however,
found that participants born in the U.S.
did not differ significantly from those
living in the U.S. for 5 years or less but
did differ reliably from those living in the
U.S. for more than 10 years. The present
findings therefore are not consistent
with the report that immigrants to the
U.S. are healthier than U.S.-born people
of similar ethnic background (12) but is
consistent with the finding that migrant
health tends to become worse with in-
creased duration living in the U.S.
(13,14). A recent study conducted on
NHANES data from 1988–1994 and
1999–2008 suggested that with regard
to diabetes in Mexican Americans, the
“healthy migrant effect” exists, although
it is diminished when the differential in
unrecognized diabetes betweenmigrants
and nonmigrants is taken into account
(15). Thus people first coming to the
U.S. were reported to have more undiag-
nosed diabetes than people born in the
U.S. The HCHS/SOL did not observe this
migrant advantage, and the diabetes
prevalence related to length of residence
in migrants was based solely on objective
criteria.
The current study also found that
prevalence of diabetes is negatively re-
lated to education and household in-
come, and this association remains
significant after adjustments for age,
sex, BMI, Hispanic background, field
center, and time living in the U.S. This
is consistent with a large-scale meta-
analysis of type 2 diabetes incidence
and socioeconomic status carried out
worldwide (16). The investigators found
that risk of getting type 2 diabetes was
associated with low socioeconomic sta-
tus including education and income in
high-, middle-, and low-income coun-
tries, but the relationship was strongest
in high-income countries such as the
U.S. In a study conducted using NHANES
data from 2001–2006, which combined
education and income to obtain an in-
dex of socioeconomic status, a strong
inverse socioeconomic gradient of car-
diovascular disease risk was found in all
race/ethnicity groups except foreign-
born Mexican American men (17). The
study did not account for length of time
participants lived in the U.S., however,
and the analysis of Hispanics/Latinos
was limited to Mexican Americans. In
any event, findings from the HCHS/SOL
confirm that negative associations exist
between diabetes prevalence and both
income and education.
Many people with diabetes in the cur-
rent study were unaware of their diabe-
tes (41.3%), had poor glycemic control
(52.0% had A1C$7.0% [53 mmol/mol]),
and/or lacked health insurance (47.9%).
The rate of diabetes awareness, how-
ever, appears to be the same as those
reported for non-Hispanic whites (9)
and increased significantly with age. In
contrast, the rate of adequate glycemic
control (A1C, 7.0;,53 mmol/mol) for
Hispanics/Latinos in the HCHS/SOL
(48.0%) appears to be somewhat lower
than those for non-Hispanic whites
(52.9%) and non-Hispanic blacks
(52.6%) observed in the NHANES for
2007–2010 (18). The rate of glycemic
control for Hispanics/Latinos in the
NHANES was 47.3%, which, together
with the HCHS/SOL findings, suggests
that fewer Hispanics/Latinos with diabe-
tes have adequate glycemic control. Dif-
ferences in health insurance and
glycemic control increased with age
and particularly for health insurance;
these differences may have been due
to Medicare enrollment. Although the
HCHS/SOL enrolled a relatively small
number of individuals between the
ages of 65 and 74 years, participants
65 years and older were more likely to
have health insurance and revealed
better glycemic control than those
who were younger. Interestingly, the
Figure 3—Rate (and SE) of health insurance,
diabetes awareness, and A1C control among
diabetic participants with diabetes in three
age groups. Data are weighted and age stan-
dardized using 2010 U.S. population census.
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percentage of Hispanic/Latino adults
aged 18–64 years lacking health insur-
ance in the NHIS for 2008 was 41.6%
compared with 14.6% in non-Hispanic
whites and 22.1% in non-Hispanic blacks
(19). A meta-analysis comparing A1C
levels between Hispanic/Latinos and
non-Hispanic white adults with diabetes
has reported that A1C was 0.5% (5.5
mmol/mol) higher in the Hispanic/
Latino patients (20). Although the rea-
sons for the disparity in glycemic control
between whites and Hispanics/Latinos
have not been investigated, the appar-
ent similarity of diabetes awareness
between non-Hispanic whites and
Hispanics/Latinos in conjunction with a
large disparity in health insurance be-
tween the groups suggests that the dif-
ferences in health insurance and/or
other aspects of access to health care
(e.g., ability to meet copayments) may
well account for the differences in gly-
cemic control. This appears to be partic-
ularly important in terms of public
health and clinical medicine, because a
decrease of 0.5% (5.5 mmol/mol) in A1C
is associated with a 10.5% decrease in
risk of vascular complications (21).
Although a major strength of the
HCHS/SOL was the use of population-
based sampling strategies, it should be
noted that of those eligible for the
study, 42% chose to enroll. Because
the study entailed a 6.5 h clinical exam
and participants could not really be
compensated for lost wages and child
care, it was essential that the study de-
sign include statistical adjustment for
nonresponse so that data estimates
are representative of the communities
from which participants were drawn.
A further limitation of the study is that
it did not differentiate type 1 from type 2
diabetes. However, study participants
ranged in age from 18–74 years, with
only 2.6% of those 18–29 years of age
having diabetes. Consequently, one can
surmise that the overwhelming percent-
age of participants with diabetes in the
HCHS/SOL have type 2 diabetes.
The design of the HCHS/SOL has been
conducive to the examination of varia-
tions in diabetes prevalence among spe-
cific Hispanic/Latino heritage groups
living in the U.S., including Central
Americans, Cubans, Dominicans, Mexi-
cans, Puerto Ricans, and South Ameri-
cans. This design is facilitating detailed,
comprehensive examination in four
large urban centers concerning the risk
factors, health habits, and prevalence of
several chronic diseases. Thus, for ex-
ample, we have observed a differential
prevalence in diabetes ranging from
10.2 to 18.3% among different
Hispanic/Latino-background groups.
However, a limitation of the HCHS/SOL
is that its design does not provide for a
representative sample of all Hispanic/
Latino heritage groups in terms of their
demography (e.g., rural versus urban
background; Mexican Americans in
Texas) and proportion of the total His-
panic/Latino and total U.S. population.
According to the U.S. census, the U.S.
Hispanic/Latino population in 2010
made up 16% of the total U.S. popula-
tion and among Hispanics/Latinos in-
cluded 63.0% Mexicans, 9.2% Puerto
Ricans, 7.9% Central Americans, 5.5%
South Americans, 3.5% Cubans, and
2.8% Dominicans (2). In order to make
inferences about disparities in diabetes
prevalence among Hispanics/Latinos liv-
ing in the U.S. one must take two obser-
vations into account. The first finding is
that diabetes prevalence ranged from
10.2 to 18.3% among heritage groups
in the HCHS/SOL. The second observation
is that four of these groups (Mexicans,
Puerto Ricans, Central Americans, and
Dominicans) all had prevalence rates
above 18% and that these four groups
make up 82.9% of the Hispanic/Latino
population in the U.S. Thus the HCHS/
SOL data document a large variation in
diabetes prevalence among Hispanic/
Latino heritage groups but are also consis-
tent with previous findings that Hispanic/
Latinos have a greater prevalence of dia-
betes than non-Hispanic whites (10,19).
The HCHS/SOL findings document a
low rate of enrollment in health insur-
ance plans among Hispanics/Latinos
with diabetes together with a need for
increasing awareness and glycemic con-
trol in Hispanics/Latinos with diabetes.
Potential implications for public health
policy, including need for increased ac-
cess to health care, appear to be partic-
ularly importantwhen one examines the
present findings indicating a significant
negative relationship between diabetes
prevalence and household income. In-
terestingly, participants in the HCHS/
SOL with diabetes who were 65 years
or older were more likely to have health
insurance and showed better glycemic
control than younger participants with
diabetes. Since those persons 65 years
and older typically had modest house-
hold incomes, our results suggest that
increasing access to health insurance
and medical care for those under 65
years would likely improve both diagno-
sis of diabetes and glycemic control.
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